Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term ...
Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
FOX CHASE, Pa. -- Bladder cancer is one of the most common cancers - just behind melanoma. Yet, many people don't know much about it. Doctors are now using a diagnostic tool to better find and ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
In patients with suspected muscle-invasive bladder cancer (MIBC), definitive treatment can be expedited by adding multi-parametric magnetic resonance imaging (mpMRI) to flexible cystoscopic biopsy at ...
Bladder cancer is a complex disease that poses high risks of morbidity and mortality, especially when not treated optimally. Hematuria is the most common presenting symptom in patients with bladder ...
Bladder cancer affects approximately 83,000 Americans each year, yet remains one of the most overlooked forms of cancer despite having excellent survival rates when caught early. This disconnect ...
Hosted on MSN
Risk Factors and Warning Signs of Bladder Cancer
Bladder cancer is often overlooked, but a recent high-profile diagnosis is helping raise awareness. Football legend and Colorado head coach Deion Sanders recently revealed he had been diagnosed at age ...
A urinary DNA methylation test demonstrated high sensitivity and specificity for detecting high-grade or invasive bladder cancer, outperforming both nuclear matrix protein 22 (NMP22) and urine ...
Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results